NASDAQ · NSPR

InspireMD, Inc.

Closing price · Nov 13, 2026 $0.6441
Last insider buy price $0.88 Paid by Director Paul Stuka on May 27, 2026 (Form 4). Not today's price.

Latest quarter · ended Jun 30, 2026

Sales slipped and cash got weaker

descriptionFiled Aug 14, 2026
Revenue growthShrinking
−0.4%
Quarter ended Sep 30, 2024: +16.3% sales vs. a year beforeQuarter ended Dec 31, 2024: +10.7% sales vs. a year beforeQuarter ended Mar 31, 2025: +1.2% sales vs. a year beforeQuarter ended Jun 30, 2025: +2.2% sales vs. a year beforeQuarter ended Sep 30, 2025: +39.4% sales vs. a year beforeQuarter ended Dec 31, 2025: +61.6% sales vs. a year beforeQuarter ended Mar 31, 2026: +122.2% sales vs. a year beforeQuarter ended Jun 30, 2026: −0.4% sales vs. a year before
Sep '24Jun '26
$1.77M vs. $1.78M a year ago
Gross marginWorse
-43.7%
Quarter ended Sep 30, 2024: 22.9% gross marginQuarter ended Dec 31, 2024: 24.1% gross marginQuarter ended Mar 31, 2025: 19.1% gross marginQuarter ended Jun 30, 2025: 17.6% gross marginQuarter ended Sep 30, 2025: 34.2% gross marginQuarter ended Dec 31, 2025: 37.5% gross marginQuarter ended Mar 31, 2026: 20.2% gross marginQuarter ended Jun 30, 2026: -43.7% gross margin
Sep '24Jun '26
vs. 17.6% a year ago
Cash from operationsWorse
−$10.9M
Quarter ended Sep 30, 2024: −$5.7M cash from operationsQuarter ended Dec 31, 2024: −$6.75M cash from operationsQuarter ended Mar 31, 2025: −$8.79M cash from operationsQuarter ended Jun 30, 2025: −$8.33M cash from operationsQuarter ended Sep 30, 2025: −$8.63M cash from operationsQuarter ended Dec 31, 2025: −$9.35M cash from operationsQuarter ended Mar 31, 2026: −$12.3M cash from operationsQuarter ended Jun 30, 2026: −$10.9M cash from operations
Sep '24Jun '26
vs. −$8.33M a year ago
Share countDiluting
+11.4%
Quarter ended Sep 30, 2024: 26.08M sharesQuarter ended Dec 31, 2024: 29.69M sharesQuarter ended Mar 31, 2025: 30.64M sharesQuarter ended Jun 30, 2025: 41.72M sharesQuarter ended Sep 30, 2025: 42.37M sharesQuarter ended Dec 31, 2025: 46.8M sharesQuarter ended Mar 31, 2026: 46.84M sharesQuarter ended Jun 30, 2026: 46.49M shares
Sep '24Jun '26
46.49M shares vs. 41.72M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −50
  • account_balance
    0 funds bought, 1 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
  • info
    11 real insider sales in 12 months. $127K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

38 funds report owning NSPR, up from 36

Holdings as of Jun 30, 2026
New7
Added10
Held16
Trimmed5
Sold out5

Last quarter

Who bought and who sold

Apr–Jun 2026
Velan Capital Investment Management LP
−93%

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Dec 30 · 55,556 shStock grant · Jan 14 · 484,295 sh · 6 peopleStock grant · Jan 14 · 680,085 sh · 2 peopleStock grant · Jan 14 · 226,695 shStock grant · Jan 14 · 1.11M shOpen-market buy · Dec 4 · $18.7KOpen-market buy · Dec 5 · $9.44KOpen-market buy · Dec 9 · $9.18KOpen-market sale · Jan 15 · $4.6KOpen-market sale · Jan 16 · $3.62KOpen-market sale · Jan 20 · $4.7KOpen-market sale · Jan 21 · $28.5KOpen-market sale · Jan 22 · $13.2KOpen-market sale · Jan 27 · $7.94KOpen-market sale · Jan 28 · $20.5KOpen-market sale · Jan 29 · $8.25KOpen-market sale · Jan 30 · $4.73KOpen-market sale · Feb 2 · $7.88KOpen-market buy · May 6 · $20.1K · 2 peopleOpen-market buy · May 7 · $198K · 3 peopleOpen-market buy · May 8 · $76.1KOpen-market buy · May 11 · $11.9KOpen-market buy · May 12 · $25.2KOpen-market buy · May 13 · $11.6KOpen-market buy · May 14 · $5.75KOpen-market sale · May 19 · $23KOpen-market buy · May 27 · $17.6K
CEOCFOOther officersDirectorsDecFebAprJunAugOctStock grant · Dec 30 · 55,556 shStock grant · Jan 14 · 484,295 sh · 6 peopleStock grant · Jan 14 · 680,085 sh · 2 peopleStock grant · Jan 14 · 226,695 shStock grant · Jan 14 · 1.11M shOpen-market buy · Dec 4 · $18.7KOpen-market buy · Dec 5 · $9.44KOpen-market buy · Dec 9 · $9.18KOpen-market sale · Jan 15 · $4.6KOpen-market sale · Jan 16 · $3.62KOpen-market sale · Jan 20 · $4.7KOpen-market sale · Jan 21 · $28.5KOpen-market sale · Jan 22 · $13.2KOpen-market sale · Jan 27 · $7.94KOpen-market sale · Jan 28 · $20.5KOpen-market sale · Jan 29 · $8.25KOpen-market sale · Jan 30 · $4.73KOpen-market sale · Feb 2 · $7.88KOpen-market buy · May 6 · $20.1K · 2 peopleOpen-market buy · May 7 · $198K · 3 peopleOpen-market buy · May 8 · $76.1KOpen-market buy · May 11 · $11.9KOpen-market buy · May 12 · $25.2KOpen-market buy · May 13 · $11.6KOpen-market buy · May 14 · $5.75KOpen-market sale · May 19 · $23KOpen-market buy · May 27 · $17.6K

Last 12 months. No real trades in the last 6.

Showing 25 real trades. Hidden: 11 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

May 27 Paul Stuka Director Open-market buy $17.6K 20,000 sh at $0.88
May 19 Shane Gleason Chief Commercial Officer Open-market sale $23K 22,778 sh at $1.01 Sold 2% of stake
May 14 Paul Stuka Director Open-market buy $5.75K 5,000 sh at $1.15
May 13 Paul Stuka Director Open-market buy $11.6K 10,000 sh at $1.16
May 12 Marvin Slosman CEO and President, Director Open-market buy $25.2K 21,000 sh at $1.20
May 11 Paul Stuka Director Open-market buy $11.9K 10,000 sh at $1.19
May 8 Paul Stuka Director Open-market buy $76.1K 65,626 sh at $1.16
May 7 Gary Roubin Director Open-market buy $106K 90,000 sh at $1.18
May 7 Scott Ward Director Open-market buy $84.2K 73,255 sh at $1.15
May 7 Paul Stuka Director Open-market buy $7.33K 6,378 sh at $1.15
Show 15 older real trades
May 6 Scott Ward Director Open-market buy $18.4K 15,995 sh at $1.15
May 6 Paul Stuka Director Open-market buy $1.7K 1,517 sh at $1.12
Feb 2 Shane Gleason Chief Commercial Officer Open-market sale $7.88K 4,941 sh at $1.59 Sold 1% of stake
Jan 30 Shane Gleason Chief Commercial Officer Open-market sale $4.73K 2,900 sh at $1.63 Sold 1% of stake
Jan 29 Shane Gleason Chief Commercial Officer Open-market sale $8.25K 5,000 sh at $1.65 Sold 1% of stake
Jan 28 Shane Gleason Chief Commercial Officer Open-market sale $20.5K 12,395 sh at $1.65 Sold 1% of stake
Jan 27 Shane Gleason Chief Commercial Officer Open-market sale $7.94K 4,781 sh at $1.66 Sold 1% of stake
Jan 22 Shane Gleason Chief Commercial Officer Open-market sale $13.2K 8,411 sh at $1.57 Sold 1% of stake
Jan 21 Shane Gleason Chief Commercial Officer Open-market sale $28.5K 17,593 sh at $1.62 Sold 1% of stake
Jan 20 Shane Gleason Chief Commercial Officer Open-market sale $4.7K 2,955 sh at $1.59 Sold 1% of stake
Jan 16 Shane Gleason Chief Commercial Officer Open-market sale $3.62K 2,250 sh at $1.61 Sold 1% of stake
Jan 15 Shane Gleason Chief Commercial Officer Open-market sale $4.6K 2,909 sh at $1.58 Sold 1% of stake
Dec 9 Paul Stuka Director Open-market buy $9.18K 5,073 sh at $1.81
Dec 5 Paul Stuka Director Open-market buy $9.44K 5,073 sh at $1.86
Dec 4 Paul Stuka Director Open-market buy $18.7K 10,130 sh at $1.85

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in NSPR

As of Jun 30, 2026
FundOwnsValueChange
Rosalind Advisors, Inc.8.4%$2.73MSame
Aberdeen Group PLC8.0%$2.59M+17%
Nantahala Capital Management, LLC7.3%$2.36MSame
Orbimed Advisors LLC6.7%$2.19MSame
Parkman Healthcare Partners LLC5.2%$1.69MSame

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist